home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops  
 

Webinar on Continued Process Verification - Process Monitoring

 
  March 04, 2016  
     
 


Compliance Trainings, Online
2016-03-10


Description :

The FDA’s Process Validation Guidance calls for “Continued Process Verification” in Stage 3 of the Guidance which focuses on continual assessment of process performance and product quality throughout the life of the product. Combining process control with process improvement creates a system that satisfies the direction of ICH Q8 (R2) and FDA’s guidance for continued process verification, continuous improvement and life cycle management. This presentation describes a disciplined and structured “Quality by Design” approach to achieve this objective.

The QbD “Design Space” concept has been given much attention by pharma and biotech industries but much less attention has been given to implementation of “process control” systems needed to keep the process in-control and consistently producing quality product. Process data are routinely analyzed at two levels to assess process stability and capability. During the production of each batch data are collected by the process operators and Quality Control to assure within batch stability and capability and that appropriate actions are taken when needed. On a monthly or quarterly basis, the batch-to-batch variation in product parameters is analyzed to assess the long-term stability and capability of the process. This system is illustrated and discussed in detail. Critical questions and challenges are identified. Connections of this system to process robustness are also addressed.

Areas Covered in the Session :

FDA Guidance regarding Process Validation and Continued Process Verification

Building Blocks of QbD – Design Space, Process Control and Assessing Risk

Process Control Strategy - Stability and Capability Methods

Process Performance and Product Quality - A Systems Approach

The Vision  for Process Monitoring and Control Building Blocks

Successful Deployment, Getting Started and Sustaining the Initiative

Tips and traps – What to watch out for

Who Will Benefit:

Executives and Managers of Pharma and Biotech Companies

Process and Manufacturing Engineers

Quality Assurance Personnel

Regulatory Affairs Professionals

Quality Control Lab Personnel

Quality Engineers

Research and Development Scientists

Biologists and Microbiologists

 

Chemists and Chemical Engineers

 
 
Organized by: Compliance Trainings
Invited Speakers:

Ronald D. Snee, PhD, is Founder and President of Snee Associates, a firm dedicated to the successful implementation of process and organizational improvement initiatives. He provides guidance to senior executives in their pursuit of improved business performance using Quality by Design, Lean Six Sigma and other improvement approaches that produce bottom line results. Prior to his consulting career he spent 24 years at the DuPont Company in a variety of assignments including pharmaceuticals. He has been developing and applying QbD methodologies for more than 30 years.

 
Deadline for Abstracts: 2016-03-10
 
Registration:

For more information about this event please visit

https://compliancetrainings.com/SiteEngine/ProductDetailView.aspx?id=FDB1437

 

To register this webinar

https://compliancetrainings.com/siteengine/Login.aspx 

E-mail: suzzane.d@compliancetrainings.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.